Dr. Steven K. Rowe is an accomplished Cardiologist with extensive experience in Cardiovascular Research and Interventional Cardiology.
After graduating from Baylor College of Medicine in 1990, Dr. Rowe joined the Mid America Heart Institute at St. Luke’s Hospital in Kansas City, Missouri. During his time at Saint Luke’s, Dr. Rowe rose to Co-Director of the Cardiac Cath Lab – offering the most comprehensive care in Kansas City. While Co-Directing the Cath Lab, Saint Luke’s Hospital was repeatedly recognized for excellence in cardiology and heart surgery and had the unique distinction of being the only regional facility providing a full range of cardiovascular services, from prevention to heart transplantation.
In 1998, Dr. Rowe left Saint Luke’s Hospital to serve as Medical Director of Cardiology at Heartland Regional Medical Center in St. Joseph, Missouri. In 2000, under Dr. Rowe’s leadership, Heartland was awarded the Solucient 100 Top Hospitals ® Cardiovascular Benchmarks for Success for demonstrating superior clinical, operational and financial performance. In 2001, and again in 2003 Excellence in Missouri Foundation awarded Heartland Health its Missouri Team Quality Award (MTQA) for demonstrating role-model processes to reach improvement goals. Dr. Rowe served as Medical Director until 2003.
In 2003, Dr. Rowe and family moved to Kansas City, at this time he joined award-winning Shawnee Mission Medical Center as Director of the Cardiac Catheterization Lab. In this capacity Dr. Rowe pushed Shawnee Mission Medical Center to invest in sophisticated medical technology. These investments paid off as SMMC quickly became the regional destination for cardiac care. In part due to Dr. Rowe’s efforts, SMMC was named one of the nation’s 100 Top Hospitals® in 2002, 2004 and 2005 by Solucient, a leading source of healthcare business intelligence.
In January of 2009, Dr. Rowe left Shawnee Mission Medical Center and joined the Ferrell Duncan Clinic in partnership with CoxHealth, the region’s largest locally owned health system in Springfield, Missouri. As Medical Director of Cardiovascular Clinical Research at CoxHealth, the Wheeler Heart and Vascular Center has quickly emerged as southwest Missouri’s premier outpatient facility for diagnostic and minimally invasive cardiac and vascular care; featuring nuclear cardiology, echocardiography and vascular ultrasound, plus innovative programs for heart failure and cardiopulmonary rehab.
In addition to conducting clinical trials, Dr. Rowe has helped CoxHealth pioneer advanced minimally invasive cardiac procedures; on May 15th, 2013, he helped perform the health system’s first transcatheter aortic valve replacement (TAVR). This minimally invasive method (Approved by United States FDA in November 2011) offers a number of benefits to patients, including shorter recovery time and less post-procedure pain. TAVR has quickly proved to be a landmark procedure for cardiology, helping patients with severe symptomatic aortic stenosis (narrowing of the aortic valve opening) who are not candidates for traditional open chest surgery or are high-risk operable candidates. Learn More about TAVR >>